Biomarkers for Cardiotoxicity Monitoring: Do We Really Need Them, Or Are They Just Extra Baggage? (Con)
Nohria, Anju
( Brigham and Womens Hospital
, Boston
, Massachusetts
, United States
)
Asnani, Aarti
( Beth Israel Deaconess
, Arliton
, Massachusetts
, United States
)
Author Disclosures:
Anju Nohria:DO have relevant financial relationships
;
Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now)
; Other (please indicate in the box next to the company name):Teledoc:Active (exists now)
; Other (please indicate in the box next to the company name):American College of Cardiology:Active (exists now)
; Consultant:Takeda Oncology:Active (exists now)
; Consultant:Regeneron:Past (completed)
; Consultant:Altathera:Past (completed)
; Consultant:AstraZeneca:Active (exists now)
| Aarti Asnani:DO have relevant financial relationships
;
Research Funding (PI or named investigator):Genentech:Active (exists now)
; Royalties/Patent Beneficiary:UpToDate:Active (exists now)
; Speaker:OncLive:Past (completed)
; Ownership Interest:Corventum:Active (exists now)